PMC:7594251 / 118445-118551 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T154","span":{"begin":26,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T155","span":{"begin":73,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"Underlying mechanisms of (A) Traditional High-throughput Screening, and (B) Fragment Based Drug Discovery."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1929","span":{"begin":41,"end":45},"obj":"Gene"}],"attributes":[{"id":"A1929","pred":"tao:has_database_id","subj":"1929","obj":"Gene:104137"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Underlying mechanisms of (A) Traditional High-throughput Screening, and (B) Fragment Based Drug Discovery."}